Navigation Links
A Novel Method Of Detection Of High Nuclear Grade Localized Renal Cell Carcinoma

Elective nephron-sparing surgery (NSS) is considered appropriate for small renal cell carcinoma (RCC) tumors; however, it is still difficult to detect high nuclear grade RCC preoperatively. //

Although no specific tumor markers have been identified for RCC, immunosuppressive acidic protein (IAP) is a variable predictor of lymph node and distant metastasis in patients with RCC. At present it is impossible to determine the nuclear grade of RCC without removing the kidney.

Researchers from the Department of Urology, Nihon University School of Medicine, Tokyo, Japan evaluated clinicopathologic factors in an effort to identify a potentially useful preoperative predictor of high nuclear grade RCC.

The investigation, published in the October issue of the journal Urology consisted of 181 patients with histologically confirmed clear cell RCC. The positive predictive value, sensitivity, and specificity for detecting nuclear grade RCC were calculated individually for the largest tumor diameter. Hemoglobin, alkaline phosphatase, C-reactive protein (CRP), ferritin, and IAP levels were also determined in all patients preoperatively. Results obtained showed that a higher than normal C-reactive protein and IAP was associated with a 252% and 405% increase in the odds of a high nuclear grade, respectively. In the Stage T1 cases, elevated IAP was also associated with a 989% increase in the odds of a high nuclear grade.

AP level may thus be a useful predictor for detecting high nuclear grade localized RCC preoperatively. The results of this study demonstrated the effectiveness of CRP and IAP measurement as a means to detect high nuclear grade RCC preoperatively.

Although this study included only a small number of cases, the authors believe that the measurement of these acute-phase reactants alone or in combination with other acute-phase reactants can be readily extended to clinical situations in which the maximal tumor diameter and ot
'"/>




Page: 1 2

Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
(Date:12/4/2009)SAN FRANCISCO, Dec. 4 Medithrive, Inc. has won the Patient,s Choice Award as the favorite dispensary in the SF Bay Area by popular vote conducted by the online website, www.weedmaps.com. Despite on
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)ANAHEIM, Calif., Dec. 4 Pamela Bowen, Chief Information Officer at Crescent Healthcare, was selected as a finalist for the "Chief Innovation Officer" Appy Award for transforming Crescent,s business w
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:Crescent CIO '09 Dreamforce Conference Speaker and Award Finalist 2Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2
... good reason to consider taking finasteride, a wel...tate and reduces the risk of getting prostate canc...ncology Group strongly suggests that for men at ri...they are most easily treatable. , It appears that...
...Risks in 236 Countries and Territories and ...on-Specific Disease Information & Vital Profiles o...he World, BALTIMORE, Sept. 11 Combining their re...health,information website ever developed for inte...
...,Imaging Ltd. (Nasdaq: EMITF ) ("EMI") announced ...e "Offering Prospectus") in Israel for the offerin...egate principal amount of,NIS 440 million. These ...provides that the maximum interest rate of the Ser...
...he most on health care when compared to other Orga...(OECD) countries. Health care prices and higher pe... spending, according to a study by researchers at ...r health resourcesphysicians, nurses and hospital ...
...ices,International Inc. (Pink Sheets: MSITF) wishe...ts VScan HIV test kit and the VScan Hepatitis C,te...allow it to apply for,EU approval of both test kit...,when EU approval is received that it will result ...
...cancer is the,second leading cause of cancer death...mately 40,460 women in the U.S. will die from the ...sed with invasive breast cancer die,from the disea...rican,American women, has teamed up with Diahann C...
Other Medicine News:Health News:Generic prostate drug helps find high-risk cancers early 2Health News:Generic prostate drug helps find high-risk cancers early 3Health News:MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers 2Health News:MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers 3Health News:Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel 2Health News:Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel 3Health News:Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel 4Health News:United States continues to have highest level of health spending 2Health News:Medical Services International Inc. Completes Testing for European Union (EU) Application 2Health News:Especially Yours and Paula Young Team up with Diahann Carroll and Jaclyn Smith in the Fight Against Breast Cancer 2
(Date:12/4/2009)MORRISTOWN, N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed
(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab
(Date:12/3/2009)ALISO VIEJO, Calif. and STATE COLLEGE, Pa., Dec. 3 Ambry Genetics and SoftGenetics today announced the signing of an agreement to provide extended bioinformatics genomics services using SoftGenetics,
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 2Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects 3CSC to Help Georgia Hospital Association Members Achieve Meaningful Use of Electronic Health Records 53827 1CSC to Help Georgia Hospital Association Members Achieve Meaningful Use of Electronic Health Records 53827 2AEterna Zentaris to Present at Upcoming Canaccord Adams 29th Annual Global Growth Conference 13410 1Micromet Inc Reports Second Quarter 2009 Financial Results 53819 1Micromet Inc Reports Second Quarter 2009 Financial Results 53819 2Micromet Inc Reports Second Quarter 2009 Financial Results 53819 3Micromet Inc Reports Second Quarter 2009 Financial Results 53819 4Micromet Inc Reports Second Quarter 2009 Financial Results 53819 5Micromet Inc Reports Second Quarter 2009 Financial Results 53819 6Micromet Inc Reports Second Quarter 2009 Financial Results 53819 7Micromet Inc Reports Second Quarter 2009 Financial Results 53819 8Micromet Inc Reports Second Quarter 2009 Financial Results 53819 9Micromet Inc Reports Second Quarter 2009 Financial Results 53819 10Micromet Inc Reports Second Quarter 2009 Financial Results 53819 11
Ministim® MS-1B Miniature Nerve Stimulator
...ntrol allows hands-free operation in nerve locator...SoloStim provides a wide range when distant from n...ported by Life-Techs complete selection of periphe... proven ProBloc™ single injection needles an...
...u deliver unmatched performance through patient-fo...complete anesthesia solution developed, putting pa...fingertips., ,The Aisys Carestation is built on o...sia delivery and patient monitoring technology. We...
...ght polypropylene mesh which offers an excellent b...ced considerably. Optilene Mesh LP is the alternat...ocedures. It perfectly conforms,to anatomical st...e Mesh LP adapts to the movements of the patient r...
Medicine Products: